# Ph 1 Study of ADI PEG 20 in Pediatric Subjects Who Are Argininosuccinate Synthetase (ASS) Deficient

> **NCT01528384** · PHASE1 · COMPLETED · sponsor: **Polaris Group** · enrollment: 8 (actual)

## Conditions studied

- Argininosuccinate Synthetase Deficient

## Interventions

- **DRUG:** ADI-PEG 20

## Key facts

- **NCT ID:** NCT01528384
- **Lead sponsor:** Polaris Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2014-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01528384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01528384, "Ph 1 Study of ADI PEG 20 in Pediatric Subjects Who Are Argininosuccinate Synthetase (ASS) Deficient". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01528384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*